Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to ...

Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...

During the fiscal year 2025 first quarter, the Company paid an aggregate principal amount of approximately $32.4 million outstanding under its term loan B facility that had an interest rate of 300 ...

Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...

She researched others with T1D and even found an article about Kansas City Chiefs tight end Noah Gray, who had made the NFL after his own discovery. A year later, after the Chiefs defeated the ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...